FAPP MIXTURE is a Subcutaneous Injection, Solution in the Non-standardized Allergenic category. It is labeled and distributed by Alk-abello, Inc.. The primary component is Gibberella Zeae; Aspergillus Niger Var. Niger; Aspergillus Repens; Aspergillus Flavus Var. Oryzae; Aspergillus Terreus; Penicillium Chrysogenum Var. Chrysogenum; Phoma Exigua Var. Exigua.
| Product ID | 0268-8025_25c99df0-1f9c-45e1-950b-88e8cb11ed1d | 
| NDC | 0268-8025 | 
| Product Type | Non-standardized Allergenic | 
| Proprietary Name | FAPP MIXTURE | 
| Generic Name | Aspergillus Flavus Var. Oryzae, Aspergillus Niger Var. Niger, Aspergillus Repens, Aspergillus Terreus, Gibberella Zeae, Penicillium Chrysogenum Var. Chrysogenum, Phoma Exigua Var. Exigua | 
| Dosage Form | Injection, Solution | 
| Route of Administration | SUBCUTANEOUS | 
| Marketing Start Date | 1965-01-01 | 
| Marketing Category | BLA / BLA | 
| Application Number | BLA103753 | 
| Labeler Name | ALK-Abello, Inc. | 
| Substance Name | GIBBERELLA ZEAE; ASPERGILLUS NIGER VAR. NIGER; ASPERGILLUS REPENS; ASPERGILLUS FLAVUS VAR. ORYZAE; ASPERGILLUS TERREUS; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PHOMA EXIGUA VAR. EXIGUA | 
| Active Ingredient Strength | 20000 [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL; [PNU]/mL | 
| Pharm Classes | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Non-Standardized Fungal Allergenic Extract [EPC],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2021-12-31 | 
| Marketing Start Date | 1965-01-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | BLA | 
| Application Number | BLA103753 | 
| Product Type | NON-STANDARDIZED ALLERGENIC | 
| Marketing Start Date | 1965-01-01 | 
| Ingredient | Strength | 
|---|---|
| GIBBERELLA ZEAE | 20000 [PNU]/mL |